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Muscle Dysmorphia (MD) is a psychological disorder characterized by the preoccupation with the 
idea that one’s body is not lean and muscular. The current study aimed to explore MD behaviours and 
symptoms in three groups of recreational athletes: bodybuilders (BB; n = 42), strength athletes (SA; 
n = 61), and fitness practitioners (FP; n = 22). Furthermore, we assessed MD-related psychological 
features as well as possible psychological predictors of MD among groups. Results highlighted that the 
BB group reported more beliefs about being smaller and weaker than desired compared to the other 
groups, whereas individuals in the SA group reported setting higher standards for themselves than 
the FP group. Lastly, orthorexia nervosa and social anxiety symptoms emerged as predictors of MD 
symptoms in the BB group. Taken together, our findings suggest that individuals in the BB group are 
characterized by more MD general symptomatology than those in the other groups; furthermore, only 
orthorexia nervosa and social anxiety may play a specific role in predicting MD general symptoms in 
bodybuilders.
Muscle Dysmorphia (MD) is a subtype of Body Dysmorphic Disorder (BDD) characterized by the preoccupation 
with the idea that one’s body is not sufficiently lean and muscular1–3. Individuals with MD perceive themselves 
as small and weak even if they look normal or very muscular2. As a consequence, individuals with MD engage 
in behaviours aimed at achieving the desired lean and muscular physique2; these behaviours are compulsive and 
are comprised of excessive exercise and rigid diet, excessive use of dietary supplements and, sometimes, may 
also include the use of anabolic-androgenic steroids (AAS)2,4–6. Individuals with MD frequently avoid important 
social or occupational activities because of the compulsive need to maintain their excessive exercise and rigid 
diet2,4.
MD affects mostly men2, and its prevalence rates vary significantly depending on the sample population; 
in particular, athletes involved in resistance training may be at increased risk for MD development compared 
to other athletes and non-trainers2,7. However, a generalization for all athletes involved in resistance training 
activities does not appear to be justified. A discrepancy of MD prevalence and features among subgroups within 
the resistance training community exists and is dependent on the goals of the weight training activity8. Indeed, 
athletes who engage in appearance-related resistance training (e.g., bodybuilders) may be at increased risk for 
MD development than athletes involved in resistance training to improve strength (e.g., weightlifters)8. In fact, 
many studies have underlined that bodybuilders display higher MD prevalence rates and more MD features than 
other resistance training athletes2,8–11 with prevalence rates ranging from 3.4%9 to 53.6%12 within this population. 
Therefore, differences in goals characterizing bodybuilders and other resistance training athletes may influence 
the prevalence and the manifestation of MD13. Although bodybuilders are considered at increased risk for devel-
oping MD2,7,8, the study by Pickett et al.14 reported that competitive bodybuilders did not differ from other resist-
ance training athletes with respect to the self-evaluation of their body image; furthermore, both groups reported 
higher positive self-evaluation of their body than physically active controls. Moreover, both competitive body-
builders and resistance training athletes were more satisfied about their upper torso muscles and general muscle 
tone than physically active controls. Finally, competitive bodybuilders reported higher levels of social self-esteem 
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than both resistance training athletes and athletically active controls14. These inconsistent findings may be due to 
sampling methods (e. g. different level of competition) and by the self-report measures employed to assess MD 
that may fail in the evaluation of the condition’s key features13.
Dysfunctional eating patterns, as well as psychological features such as perfectionism, self-esteem, and social 
anxiety, may play a key role in the development and maintenance of MD4,15,16. MD shares clinical features with 
Eating Disorders (EDs), because of the presence of the compulsive exercise and rigid diet characterizing both 
disorders; accordingly, previous studies have well documented the high comorbidity between MD and EDs5,17, 
but little is known about dysfunctional eating patterns, such as Orthorexia Nervosa (ON) in individuals with 
MD. ON is defined as an obsession for healthy food and differs from EDs since dysfunctional eating patterns are 
expressed in a “qualitative” way rather than in a “quantitative” one5,18. Indeed, in order to obtain the desired lean 
and muscular physique, individuals with MD usually strictly control what they eat, and their food choices are 
focused on the healthy aspects of the food19. Furthermore, men’s internalization of a muscular body ideal, typical 
of men with MD, plays a significant role in relation to ON. The internalization of a muscular body ideal is related 
to higher scores of ON which explains why ON is common in individuals with MD18,20.
Perfectionism might be involved in MD development and maintenance, given that individuals with MD strug-
gle to reach an unattainable body shape8,16. Perfectionism may influence the development of MD both directly and 
indirectly; the direct influence relies in the pursuit of the perfect body, whereas the indirect influence might be 
enacted through body dissatisfaction16. Although the association between perfectionism and MD is well-known 
and established11,16, little is known about which specific components of perfectionism are actually involved in 
MD. Indeed, perfectionism is a multidimensional construct composed of three dimensions (self-oriented perfec-
tionism, other-oriented perfectionism, and socially-prescribed perfectionism)21 that may differentially contribute 
to the development and maintenance of MD.
Low self-esteem is also conceptualized as a crucial factor implicated in the development and maintenance of 
MD4,15,16,22. Individuals with MD may engage in appearance-improving behaviours (such as weightlifting, exces-
sive exercise, rigid diet, and use of dietary supplements) to enhance their self-esteem23; importantly, the muscular 
development obtained performing these activities reinforce engagement in these activities again. Therefore, low 
self-esteem can provide a source of motivation for MD behavioral symptoms23. Furthermore, low self-esteem 
may contribute to the avoidance of social situations in which the body is exposed to others, and such avoidance is 
negatively reinforced by a temporary reduction in anxiety4. Consistently, individuals with MD try to avoid places 
and situations in which their bodies might be seen by others (e.g., beaches, swimming pools) or endure such sit-
uations with marked distress and anxiety2,4. Although the role of social physique anxiety has been well explored 
with respect to MD development2,24, little is known about social anxiety in MD. Moreover, despite the fact that 
low self-esteem is theoretically linked to MD4,15,16,22, previous studies examining self-esteem in individuals con-
sidered at increased risk for MD led to inconsistent results. For example, Muller et al.25 did not observe differences 
in self-esteem between bodybuilders/weight lifters and athletes practicing other sports (contact and non-contact 
sports). Even more surprisingly, Pickett et al.14 found that competitive bodybuilders had higher social self-esteem 
than physically active controls. Such contradictory results call for further research aimed to shed light on the role 
of self-esteem in individuals considered at increased risk for MD.
Despite the recent increased interest toward this disorder and its growing prevalence26, MD is still 
under-studied and uncharted. As previously reviewed, individuals with MD are markedly distressed and/or 
impaired by their preoccupation with their perceived weakness, which negatively impacts their quality of life2,3. A 
more in-depth understanding of MD, especially in athletes at increased risk, would contribute to the development 
and implementation of effective assessment, prevention, and treatment programs, thus further leading to higher 
knowledge and awareness about this disorder.
Therefore, the current study aimed to explore MD behaviours and symptoms in three groups of Italian athletes 
who trained regularly for recreational purposes: bodybuilders (BB group), strength training athletes (SA group), 
and fitness practitioners (FP group). In accordance with previous studies, we expected to observe more MD 
behaviours and symptoms in the BB group than in the other groups25,27.
Furthermore, we investigated MD-related psychological features such as self-esteem, perfectionism, social 
anxiety, and ON symptoms among these groups of athletes (BB, ST, and FP). Since bodybuilders are more likely 
to show MD features25,27, we expected to observe lower levels of self-esteem and higher levels of perfectionism, 
as well as more ON symptoms, in the BB group than in the other two groups. Furthermore, given the association 
between MD, low-self esteem, and social anxiety2,4, we hypothesized higher levels of social anxiety symptoms in 
the BB group than in the other two groups; to note, no previous study explored social anxiety among these groups 
of athletes (BB, SA, and FP).
Lastly, we sought to explore possible MD psychological predictors among groups. In light of (1) the putative 
role played by high levels of perfectionism, social anxiety, ON symptoms, and low self-esteem in the develop-
ment and maintenance of MD4,15,16 and (2) the increased risk of MD in athletes involved in resistance training 
for appearance-related purposes2,7, we hypothesized that all the above mentioned psychological features would 
predict MD only in the BB group.
Results
Sample Description. The mean age of the total sample was 30.89 (SD = 8.90; range = 19–55), and the 
mean years of education was 15.02 (SD = 2.85; range = 8–21). The majority of participants reported being single 
(36%) and full time employed (46.4%). Groups were equivalent with respect to age (p = 0.06), years of education 
(p = 0.93), marital status (p = 0.21), and occupation (p = 0.35; Table 1), whereas differences emerged on BMI 
(p = 0.01). Bonferroni post hoc comparisons showed that the BMI of the SA group was higher than the BMI 
of the FP group (p = 0.01), while the BB group did not differ from either the SA (p = 0.06) or the FP (p = 0.99) 
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groups (Table 1). To note, eight participants (6.4%) satisfied the Pope et al. (1997) diagnostic criteria for MD: four 
bodybuilders, two strength athletes, and two fitness practitioners.
MD Behaviours and Symptoms Among Groups. With respect to behaviours related to MD, 
Chi-squared analyses showed significant group differences on daily protein intake (χ26 = 19.28; p = 0.004). 
Indeed, protein intake was >2 g proteins/kg/day only in the BB group compared to the other two groups (18 par-
ticipants vs 6 participants in the SA group and 4 participants in the FP group). Groups also differed with respect 
to AAS use (χ26 = 13.32; p = 0.04). More individuals in the BB group reported considering taking AAS (10 partic-
ipants vs 4 participants in the SA group and no one in the FP group).
With respect to MD symptoms, ANOVAs showed significant group differences on the MDDI. In particular, 
the BB group scored significantly higher on the DFS subscale than the SA (p = 0.001) and the FP (p = 0.02) 
groups, whereas no difference between the SA and the FP groups emerged (p = 0.99). Moreover, the BB group 
scored significantly higher on the total score of the MDDI than the FP group (p = 0.02), while the SA group did 
not differ from either the BB (p = 0.21) or the FP groups (p = 0.49). With respect to other MDDI subscales, no 
differences among groups emerged (MDDI AI: p = 0.59; MDDI FI: p = 0.06). Means, standard deviations, and 
comparisons are reported in Table 2.
Psychological Features Related to MD Among Groups. Significant differences among groups emerged 
with respect to the MPS self-oriented subscale. Specifically, the SA group scored significantly higher than the FP 
group (p = 0.002), whereas the BB group did not differ from both the SA (p = 0.07) and the FP (p = 0.39) groups. 
Groups did not differ on the RSES (p = 0.31), MPS other-oriented scale (p = 0.22), MPS socially prescribed scale 
(p = 0.25), SPS (p = 0.35), and ORTO-15 (p = 0.11). Means, standard deviations, and comparisons are reported 
in Table 2.
Psychological Features as Predictors of MD. BB group. In light of correlation findings, the RSES, the 
MPS socially prescribed subscale, the SPS, and the ORTO-15 were included in the second step of the two-steps 
hierarchical multiple regression. The overall model explained 49.1% of the variance in the MDDI total score. The 
DASS-21 total score was entered in the first step and significantly predicted the MDDI total score, F(1,40) = 6.62, 
p = 0.01, explaining 14% of the variation in the MDDI total score. The inclusion of the other variables in the sec-
ond step explained an additional 41% of variation in the MDDI total score (F change = 8.27; p < 0.001). Results 
showed that, after controlling for the DASS-21 total score, the SPS and the ORTO-15 were significant predictors 
BB group 
(N = 42)
SA group 
(N = 61)
FP group 
(N = 22) χ2/F df η2p p
Age 28.17 (8.14) 32.26 (9.08) 32.27 (8.97) 3.05 2,122 0.04 0.06
Education 15.10 (2.93) 14.92 (2.73) 15.14 (3.17) 0.07 2,122 0.001 0.93
Marital status (% single) 50 26.23 36.36 8.38 6 — 0.21
Occupation (% employed 
full time) 45.24 45.90 50 11.12 10 — 0.35
BMI 24.77 (2.12) 25.89 (2.36)a 24.23 (2.53) 5.32 2,122 0.08 0.01**
Table 1. Comparisons among groups on age, education, marital status, occupation and Body Mass Index 
(BMI). Note. BB = bodybuilders; SA = strength athletes; FP = fitness practitioners. **p < 0.01. aSignificantly 
different to FP.
BB group 
(N = 42)
SA group 
(N = 61)
FP group 
(N = 22) F(1,122) η2p p
MDDI desire for size 10.31 (4.32)a 7.05 (4.18) 7.14 (4.64) 7.85 0.11 0.001**
MDDI appearance intolerance 4.17 (2.94) 3.93 (3.02) 3.36 (2.84) 3.07 0.01 0.59
MDDI functional impairment 6.93 (4.20) 7.34 (3.61) 4.91 (4.51) 0.53 0.04 0.06
MDDI total score 21.40 (8.44)b 18.33 (7.83) 15.41 (9.80) 3.90 0.06 0.02*
RSES 30.74 (4.95) 31.70 (5.41) 32.77 (4.68) 1.17 0.02 0.31
MPS self-oriented 68.09 (15.67) 74.98 (15.35)c 62.14 (11.61) 6.78 0.10 0.02*
MPS other-oriented 57.17 (12.52) 60.87 (9.73) 59.91 (9.20) 1.52 0.02 0.22
MPS socially prescribed 50.40 (12.97) 54 (13.31) 50 (8.16) 1.41 0.02 0.25
SPS total score 16 (10.57) 14.18 (9.64) 12.41 (7.73) 1.05 0.02 0.35
ORTO-15 total score 34.31 (3.54) 35.80 (3.44) 35.54 (4.07) 2.24 0.03 0.11
Table 2. Comparisons among bodybuilders (BB group), strength athletes (SA group) and fitness practitioners 
(FP group) on MD and related psychological and psychopathological features. Note. MDDI = Muscle 
Dysmorphic Disorder Inventory; RSES = Rosenberg Self-Esteem Scale; MPS = Multidimensional Perfectionism 
Scale; SPS = Social Phobia Scale. *p < 0.05. **p < 0.001. aSignificantly different to SA and FP; bSignificantly 
different to FP; cSignificantly different to FP.
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(β = 0.51 t = 3.95, p < 0.001 and β = −0.24 t = −2.12, p = 0.04, respectively), whereas the RSES (p = 0.06) and the 
MPS socially prescribed (p = 0.92) subscales were not.
SA group. The RSES and the SPS were included in the second step of the two-step hierarchical multiple regres-
sion. The overall model explained 23.3% of the variance in the MDDI total score. Results showed that, at step 
one, the DASS-21 total score was a significant predictor, F(1,59) = 9.22, p = 0.004, and accounted for 13% of the 
variation in the MDDI total score. Entering the other variables in step 2 explained an additional 14% of variation 
in the MDDI total score (F change = 0.14; p = 0.01). Results indicated that, after controlling for the DASS-21 total 
score, only the SPS was a significant predictor of the MDDI total score (β = 0.37 t = 2.83, p = 0.01), while the RSES 
was not (p = 0.39).
FP group. The RSES and the SPS were included in the second step of the two-step hierarchical multiple regres-
sion. The overall model explained 40.4% of the variance in the MDDI total score. Results showed that, at step 
one, the DASS-21 total score was a significant predictor, F(1,20) = 14.22, p = 0.001, and accounted for 42% of the 
variation in the MDDI total score. Entering the other variables in step 2 did not explain additional variance in the 
MDDI total score (F change = 1.29; p = 0.30).
Discussion
MD is a subtype of BDD1 that is still under-recognized and frequently left untreated, despite its associated 
unhealthy behaviours (such as rigid adherence to dietary regimes, excessive exercise and, frequently, AAS use), 
which negatively impacts quality of life and well-being2,3. The current study aimed at expanding extant knowledge 
about MD in athletes at increased risk and, specifically, in three groups of recreational athletes: bodybuilders (BB 
group), strength athletes (SA group), and fitness practitioners (FP group).
In line with our expectations, individuals in the BB group displayed more MD-related behaviours than those 
in the other two groups; specifically, the BB group reported considering taking AAS more frequently than both 
the SA group and the FP group. Furthermore, the total protein intake was >2 g proteins/kg/day only in the BB 
group. These findings are consistent with studies underlining that being involved in sports that reward building 
muscles for appearance-related purposes, such as bodybuilding, may expose athletes to a greater risk of engaging 
in unhealthy behaviours such as use of AAS16,28. These results are also in accordance with studies reporting strict 
adherence to a high-protein diet in bodybuilders25,29. Importantly, individuals in the BB group think about tak-
ing AAS and engage in high-protein diet possibly due to dissatisfaction with their body size and shape and the 
desire to be more muscular. Accordingly, individuals in the BB group reported more beliefs about being smaller 
and weaker than desired and wished to be more muscular than the other two groups. A similar result was found 
by Lantz et al.10, who observed that bodybuilders are more likely to report body size-symmetry concerns than 
strength athletes because they are primarily interested in lifting weights to develop a mesomorphic physique, 
defined by muscular shape and symmetry. Therefore, individuals in the BB group may be concerned about their 
body size and shape and desire to be more muscular because of the goals of the weight training activity they per-
form; they struggle to reach the ideal body shape and may be concerned about failing to achieve it.
The BB group also reported more general symptomatology related to MD than the FP group, whereas no 
differences between the BB group and the SA group emerged. These results are in contrast with the meta-analysis 
by Mitchell et al.11 outlining that bodybuilders show greater MD symptomatology than strength training athletes. 
Nonetheless, these results are consistent with studies reporting that athletes involved in resistance training in 
general usually show increased MD symptoms17,30; consequently, the SA group may represent an intermediate 
group between BB and FP with respect to MD general symptomatology. Both bodybuilders and strength trainers 
usually engage in intensive sessions of weight training with the aim of increasing muscles size and strength, and 
this is achieved through intensive exercise. Thus, susceptible individuals of both groups may experience negative 
emotions when deviating from daily exercise and may experience anxiety in social situations if the desired muscle 
size and strength are not achieved. On the contrary, fitness practitioners would be less vulnerable to MD general 
sympotmatology in light of the different goals pursued through their training activity.
Regarding MD-related psychological features, no differences among groups emerged with the exception of 
self-oriented perfectionistic traits. Indeed, the SA group reported to set higher standards for themselves than the 
FP group, whereas no differences between the BB group and the FP group emerged. These findings are partially in 
line with the study by Muller et al.25, suggesting the presence of higher perfectionistic traits in bodybuilders and 
strength training athletes than in contact or noncontact sports athletes. However, the lack of differences in per-
fectionistic traits between the BB group and both the SA and the FP group was unexpected as the majority of pre-
vious studies underlined that perfectionistic traits are more prevalent in bodybuilders than in other athletes27,31. 
However, it is noteworthy that such studies focused on both competitive and recreational bodybuilders, and it 
may be possible that perfectionistic traits characterize competitive bodybuilders rather than recreational ones; 
therefore, our different sample composition (only recreational athletes) might explain discrepancies in results.
The three groups were comparable also with respect to self-esteem, orthorexic behaviours, and social anxiety 
symptoms; these results are rather unexpected. In accordance with most of literature about MD, we hypothesized 
lower levels of self-esteem27 and more orthorexic behaviours25,29 in the BB group than in both the SA and the FP 
groups. Regarding self-esteem, current findings mirror those by Muller et al.25 who failed to detect differences 
in self-esteem between bodybuilders/weight lifters and contact and non-contact sports. Similarly, Blouin and 
Goldfield27 did not find any difference in self-esteem between bodybuilders and runners, but they observed lower 
levels of self-esteem in bodybuilders than in martial athletes. Taken as a whole, current data might suggest that 
low self-esteem does not characterize bodybuilders, at least when bodybuilding is practiced with recreational pur-
poses. The same might apply to orthorexic behaviours: indeed, a strict adherence to rigid diet and the obsession 
for healthy food might be more relevant in athletes who compete32. Concerning social anxiety, Pickett et al.14 also 
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reported that symptoms of anxiety and social physique anxiety in bodybuilders are lower than, or comparable to, 
those displayed by strength training athletes and physically active controls. This may be explained, once again, by 
the absence of competitive bodybuilders in our sample. Indeed, individuals characterized by MD symptoms usu-
ally experience social anxiety symptoms in situations in which they are afraid of receiving a negative evaluation 
by others regarding their body33 which is definitely more common during competitions compared to recreational 
situations.
Lastly, findings about possible MD psychological predictors among groups showed that, within the BB group, 
MD symptomatology was predicted only by orthorexic behaviours and social anxiety symptoms. Social anxiety 
symptoms emerged as the only predictor of MD symptomatology also in the SA group. Results about social anx-
iety symptoms are somewhat in line with findings by Chandler et al.34 who underlined that these symptoms may 
represent a motivational factor underling MD symptoms through negative reinforcement. The fear of negative 
evaluation by others, especially about one’s physique, is an aversive state; since the social ideal for the male body 
is a mesomorphic physique35–37, an acceptable way to decrease social anxiety is gaining muscle through lifting 
weights. Therefore, lifting weights decreases anxiety, thus leading to the reinforcement of the weight lifting behav-
iours33. This mechanism may be peculiar for both the BB group and the SA group, given that they are both char-
acterized by intensive sessions of weight training with the aim of increasing muscles size and strength. Regarding 
orthorexic behaviours, the obsession for healthy food may contribute to MD development only in bodybuilders. 
This result is in accordance with studies affirming that the majority of individuals with MD present dysfunctional 
eating patterns characterized by rigid diet and by the avoidance of food when its caloric content is unknown 
(e.g., eating food in restaurant)4. In other words, the obsession for healthy food might act as a trigger fostering 
the engagement in MD symptoms (e.g., beliefs of being smaller and weaker than desired, or wishing to be more 
muscular) and MD-related behaviours (e.g., engaging in intensive sessions of weight training). Regarding the 
FP group, no psychological features related to MD resulted predictive for MD symptomatology; although these 
results should be interpreted with caution in light of the small sample size of the FP group, they are reasonable 
since the FP group is not considered at increased risk of developing MD symptoms.
To note, the current study is characterized by several limitations. First, the sample size was relatively small 
which likely reduces the generalizability of our conclusions. Related to this issue, the statistical power of the 
employed regression design could not guarantee a reliable detection of MD predictors; hence, regression findings 
should be interpreted with caution. Secondly, the online recruitment strategy we adopted under-sampled those 
without internet capability and prevented the opportunity of conducting face-to-face interviews of participants 
self-identified as recreational bodybuilders and recreational strength athletes. Lastly, the absence of psychometric 
information for the MPS is another limitation.
To conclude, despite the above-mentioned shortcomings, the present study represents one of the first attempts 
to assess behaviours, symptoms, and possible psychological predictors of MD among athletes who trained regu-
larly for recreational purposes. Future studies overcoming these issues are highly recommended. Indeed, to date, 
the distinction between pathological versus non-pathological pursuit of hyper muscularity has been scarcely 
addressed. Overall, the present findings suggest that the pursuit of a lean and muscular physique in bodybuild-
ers is not always associated with MD and related psychological features. Although the BB group reported more 
negative beliefs about being smaller and weaker than desired, or wished to be more muscular than the other two 
groups, bodybuilders (as a group) are not necessarily characterized by psychological features related to MD such 
as low self-esteem, high perfectionism, social anxiety symptoms, and dysfunctional eating patterns. Therefore, the 
pursuit of a lean and muscular physique that characterized bodybuilders is not a sufficient condition to develop 
MD. Unlike from athletes not characterized by MD symptoms, athletes and individuals with MD set a high stand-
ard for their ideal body that, perhaps, is far from their reach. Additionally, the perception of their body may be far 
from their actual body. Therefore, pursuing the fitness of one’s own body is not related to MD but, rather, it is how 
extreme an individual sets their ideal body, and the level of discrepancy between their ideal and current body, that 
may contribute to the development of MD.
The present findings also suggest that orthorexic behaviours may predict MD symptomatology in bodybuild-
ers; similarly, social anxiety symptoms may predict MD symptomatology both in bodybuilders and strength ath-
letes. This information is crucial because it may lead to a better understanding and recognition of MD. Improving 
the identification of predictors and risk factors for MD, as well as its associated psychological features, might 
facilitate the identification of at-risk trainers, as well as the development of prevention strategies and interven-
tions. Furthermore, a deeper understanding of MD manifestation among athletes may help to distinguishing 
individuals participating in a healthy manner versus those participating in an unhealthy manner.
Methods
Participants. Participants were 125 males who trained regularly for recreational purposes; they self-identi-
fied themselves as recreational bodybuilders (n = 42; BB group), recreational strength athletes (n = 61; SA group), 
and fitness practitioners (n = 22; FP group). All participants satisfied the following general inclusion criteria: at 
least 18 years of age; absence of severe neurological or medical conditions; no current or past psychotic disorders; 
no evidence of intellectual disabilities.
Measures. All participants completed an online brief schedule collecting socio-demographic informa-
tion, self-reported weight and height, daily protein intake, AAS use, and Pope et al.2 diagnostic criteria for MD. 
Furthermore, participants completed the following online self-report measures:
The Muscle Dysmorphic Disorder Inventory (MDDI38; Italian version by Santarnecchi & Dèttore, 201239) is a 
13 item self-report questionnaire assessing symptoms associated with muscle dysmorphia (MD) on a five-point 
Likert scale (from 0 = never to 4 = always). It contains three subscales: desire for size (DFS), appearance 
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intolerance (AI), and functional impairment (FI); a total score can also be computed. The DFS subscale assesses 
beliefs of being smaller and weaker than desired, or wishing to be more muscular. The AI is made up of ques-
tions regarding negative beliefs and anxiety associated with one’s body and appearance. Lastly, the FI assesses the 
presence of negative emotions when deviating from daily exercise or avoidance of social situations because of 
the preoccupation with one’s body. The questionnaire showed good internal consistency, with Cronbach’s alpha 
coefficients raining from α = 0.77 to α = 0.8538. The Italian version proved to be highly reliable as well, with the 
exception of the AI subscale (α = 0.45)39. In the current study, the alpha coefficient was 0.80 for the DFS scale, 
0.73 for the AI scale and 0.83 for the FI subscale. Finally, the alpha coefficient of the total score was 0.83.
The Rosenberg Self-Esteem Scale (RSES40; Italian version by Prezza, Trombaccia, & Armento, 199741) consists 
of 10 items measuring global self-esteem. Items are rated on a four-point Likert scale, ranging from 1 = strongly 
disagree to 4 = strongly agree, with higher scores representing greater self-esteem. Good internal consistency 
values have been reported for the original RSES, ranging between α = 0.77 and α = 0.8842. The Italian version 
showed good psychometric properties as well: its internal consistency was α = 0.8441. The internal consistency 
coefficient was excellent also in the present sample (α = 0.88).
The Multidimensional Perfectionism Scale (MPS)21 is a 45 item self-report questionnaire designed to assess 
three different domains of perfectionism: self-oriented, socially prescribed, and other-oriented. The self-oriented 
subscale involves self-directed perfectionistic behaviours such as setting high standards for oneself; the socially 
prescribed subscale involves the perceived need to attain standards prescribed by significant others; and the 
other-oriented subscale involves placing unrealistic standards for significant others and placing importance on 
other people being perfect. Each subscale of the questionnaire contains 15 item evaluated on a seven-point Likert 
scale (ranging from 1 = strongly disagree to 7 = strongly agree), with higher scores indicating greater levels of 
perfectionism. With respect to the original MPS, good internal consistency values have been reported, ranging 
between α = 0.79 and α = 0.89 in a student sample21. The Italian validation of the MPS is not available to date, 
therefore an ad hoc translation was employed. In the present sample, the alpha coefficient was α = 0.89 for the 
self-oriented scale, α = 0.80 for the socially prescribed scale and α = 0.72 for the other-oriented perfectionism 
subscale.
The Social Phobia Scale (SPS43; Italian version by Sica et al.44) consists of 20 item assessing situations that 
involve being observed by others (e. g., public speaking, eating in public, etc.). Items are rated on a five-point 
Likert scale, ranging from 0 = not at all to 4 = extremely, with higher scores indicating greater social phobia. 
The SPS showed good psychometric properties; its internal consistency was α = 0.90 in a community sample 
and α = 0.89 in patients with social phobia. Test-retest reliability was r = 0.91 on a 4 weeks period43. The Italian 
version proved to be highly reliable and stable as well (internal consistency: α = 0.87; 30-day test-retest reliability: 
r = 0.87)44. Internal consistency coefficient was excellent in the present sample (α = 0.89).
The ORTO-1545 is a 15 item self-report questionnaire assessing orthorexia. The questionnaire evaluates the 
presence of obsessive attitudes towards choice, preparation and consumption of healthy foods on a four-point 
Likert scale ranging from 1 = never to 4 = always, with lower scores indicating orthorexic behaviours. Cut-off 
point values can be set depending on the purpose of the study45. Within the validation sample, the ORTO-15 
demonstrated high specificity (73.6%) and high negative predictive value (100%) with a threshold value of 40 
points45.
The Depression Anxiety Stress Scale-21 (DASS-2146; Italian version by Bottesi et al.)47 is a 21 item self-report 
questionnaire assessing depression, anxiety, and stress on a four-point Likert scale (ranging from 0 = did not apply 
to me at all to 3 = applied to me very much), with higher scores indicating greater distress. Three subscale scores 
and a “general distress” total score can be computed47. The original DASS-21 demonstrated adequate reliability 
in non-clinical samples, with coefficient alphas ranging from α = 0.73 to α = 0.8146. The Italian version proved 
to be highly reliable as well, with internal consistency values ranging from α = 0.74 to α = 0.90 in a community 
sample47. For the purpose of the present research we focused only on the total score of the questionnaire. In the 
present study, the alpha coefficient for the total DASS-21 was excellent (α = 0.91).
Procedure. Bodybuilders and strength athletes were recruited online through links posted on bodybuilding 
and resistance training discussion forums (www.projectinvictus.it; www.ironmanager.it); fitness practitioners 
were recruited in public gyms and were invited to complete online self-report questionnaires. All participants 
self-identified themselves as recreational bodybuilders, recreational strength athletes, and fitness practitioners. 
All individuals participated on a voluntary basis and provided their informed consent clicking agreement before 
starting to complete the survey about male body image and related psychological features; participants were also 
informed about the possibility to withdraw from the survey at any stage without explanation. After providing 
informed consent, participants completed the brief schedule collecting socio-demographic information and the 
self-report measures; responses were saved on the Google Drive server. Participants took approximately 30 min-
utes to complete the survey.
The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethical 
Committee of the of the Psychological Sciences, University of Padova.
Statistical Analyses. In order to assess group differences on socio-demographic variables, one-way analyses 
of variance (ANOVAs) and Chi-squared analyses were conducted. Bonferroni post hoc comparisons were com-
puted when significant differences emerged.
Chi-squared analyses and one-way ANOVAs were performed in order to compare groups (BB group vs SA 
group vs FP group) regarding behaviours, symptoms, and psychological features related to MD; also in this case, 
Bonferroni post hoc comparisons were computed when appropriate.
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In order to investigate MD psychological predictors we first calculated Pearson’s correlations taking into 
account the MDDI total score and possible psychological predictors (RSES, MPS, SPS, and ORTO-15) within 
each group (BB group, SA group, and FP group) (Table 3). Finally, based on correlation findings, we performed 3 
two-step hierarchical regression analyses within each group (BB group, SA group, and FP group). The MDDI total 
score was the dependent variable and the DASS-21 total score was always included in the first block to control for 
general distress; finally, appropriated psychological variables were entered in the second block.
Conventional significance levels were used (ps < 0.05). All statistical analyses were conducted using IBM SPSS 
statistics, version 21.
Data availability. The datasets analysed during the current study are available from the corresponding 
author on reasonable request.
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